Consultations have commenced on what the Medical Research Future Fund’s next set of priorities should be. Round two priorities kick-in when the first expire in November. Oversight body the Australian Medical Research Advisory Board is looking for  advice on new ones and/or continuing those in round one.

The ’16-’18 priorities include, anti-microbial resistance, communicable disease control, drug effectiveness and repurposing, national infrastructure sharing, clinical trial network and biomedical translation.